Novartis India Q3 net profit dips 31 percent to Rs 12.87 crore
The company had posted a net profit of Rs 18.74 crore for the corresponding period of the previous fiscal, Novartis India said in a filing to BSE.
New Delhi: Drug firm Novartis India Monday reported a 31 per cent decline in net profit to Rs 12.87 crore for the quarter ended December 2018.
The company had posted a net profit of Rs 18.74 crore for the corresponding period of the previous fiscal, Novartis India said in a filing to BSE.
Read Also: Novartis Kymriah wins UK backing after initial lymphoma snub
Revenue from operations of the company stood at Rs 135.62 crore, compared with Rs 156.10 crore for the same period a year ago.
Read Also: Novartis Aimovig not cost effective: UK price watchdog
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd